Updated Jul 16, 2026 · Last SEC filing 2026-07-09
CORCEPT THERAPEUTICS INC (CORT) has filed 27 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-09. 4 Form 8-K material event filings were reported by CORT in the last 90 days. 10 Form 144 notices of proposed sale were filed for CORT stock. InsiderAlpha tracks every CORT SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001088856 |
| Form 4 filings (90d) | 27 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 10 |
| Latest Form 4 filing | 2026-07-09 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Guyer William | Chief Development Officer | M — Option exercise | 20.0K | $21.65 | $433K | SEC | |
| Guyer William | Chief Development Officer | S — Open-market sale | 19.0K | $93.11 | $1.77M | SEC | |
| Guyer William | Chief Development Officer | S — Open-market sale | 952 | $93.54 | $89K | SEC | |
| Maduck Sean | See Remarks | M — Option exercise | 25.0K | $8.27 | $207K | SEC | |
| Maduck Sean | See Remarks | S — Open-market sale | 2.8K | $88.51 | $248K | SEC | |
| Maduck Sean | See Remarks | S — Open-market sale | 11.0K | $87.33 | $963K | SEC | |
| Maduck Sean | See Remarks | S — Open-market sale | 11.2K | $89.31 | $998K | SEC | |
| MAHONEY DAVID L | Insider | S — Open-market sale | 20.0K | $84.53 | $1.69M | SEC | |
| WILSON JAMES N | Insider | S — Open-market sale | 5.8K | $83.57 | $487K | SEC | |
| WILSON JAMES N | Insider | S — Open-market sale | 4.2K | $82.69 | $345K | SEC | |
| Mokari Atabak | Chief Financial Officer | S — Open-market sale | 2 | $82.45 | $165 | SEC | |
| Mokari Atabak | Chief Financial Officer | S — Open-market sale | 19.5K | $81.81 | $1.59M | SEC | |
| Mokari Atabak | Chief Financial Officer | M — Option exercise | 40.0K | $19.26 | $770K | SEC | |
| Mokari Atabak | Chief Financial Officer | S — Open-market sale | 9.4K | $80.02 | $755K | SEC | |
| Mokari Atabak | Chief Financial Officer | S — Open-market sale | 11.1K | $80.94 | $897K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for CORCEPT THERAPEUTICS INC (CORT). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Maduck Sean | 16 | $9.99M |
| Mokari Atabak | 12 | $7.66M |
| Guyer William | 12 | $5.67M |
| Robb Gary Charles | 7 | $80K |
| WILSON JAMES N | 7 | $832K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CORT insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live CORT dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.